Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David S Miller, MD
University of Texas Southwestern Medical Center, Dallas, USA
Principal Investigator - Hani Gabra, MD
Imperial College London Hammersmith Campus, London, UK
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
123 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medizinische Universität Innsbruck
Innsbruck, Austria
- Alexandrov National Cancer Centre of Belarus
Minsk, Belarus
- Minsk City Clinical Oncologic Dispensary
Minsk, Belarus
- Mogilev Regional Clinical Oncologic Dispensary
Mogilev, Belarus
- Vitebsk Regional Clinical Oncologic Dispensary
Vitebsk, Belarus
- Institut Jules Bordet
Brussels, Belgium
- Uz Leuven - Campus Gasthuisberg
Leuven, Belgium
- Hospital Centre Liege University_chu Sart Tilman
Liège, Belgium
- Chwapi
Tournai, Belgium
- Clinical Center Banja Luka, Oncology Clinic
Banja Luka, Bosnia and Herzegovina
- University Clinical Hospital Mostar, Oncology Clinic
Mostar, Bosnia and Herzegovina
- Clinical Centre University of Sarajevo
Sarajevo, Bosnia and Herzegovina
- Specialized Hospital for Active Treatment in Obstetrics and Gynecology
Pleven, Bulgaria
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Princess Margaret Cancer Center
Toronto, Ontario, Canada
- Hopital Notre Dame - Chum
Montreal, Quebec, Canada
- Mcgill University
Montreal, Quebec, Canada
- Royal Victoria Hospital
Montreal, Quebec, Canada
- Hotel Dieu de Quebec- Chuq
Québec, Canada
- Masarykův Onkologický Ústav
Brno, Czechia
- Fakultní Nemocnice Olomouc
Olomouc, Czechia
- Všeobecná Fakultní Nemocnice V Praze
Prague, Czechia
- Copenhagen University Hospital "rigshospitalet"
Copenhagen, Denmark
- Herlev Hospital
Herlev, Denmark
- Kuopio University Hospital
Kuopio, Finland
- Tampere University Hospital
Tampere, Finland
- Turku University Central Hospital
Turku, Finland
- Universitätsklinikum Köln
Cologne, Germany
- Klinikum Frankfurt Höchst
Frankfurt, Germany
- Georg-August-Universität Göttingen, Universitäts-Frauenklinik, Abteilung Für Gynäkologie Und Geburtshilfe
Göttingen, Germany
- Universitätsklinik Und Poliklinik Für Gynäkologie Martin Luther Universität Halle-Wittenberg
Halle, Germany
- University Clinic Münster
Münster, Germany
- Klinik Für Frauenheilkunde Und Geburtshilfe Der Universität Regensburg Am Caritas-Krankenhaus St. Josef
Regensburg, Germany
- Mater Misericordiae University Hospital
Dublin, Ireland
- Mater Private Hospital
Dublin, Ireland
- St James'S Hospital
Dublin, Ireland
- University Hospital Galway
Galway, Ireland
- Waterford Regional Hospital
Waterford, Ireland
- Barzilai Medical Center
Ashkelon, Israel
- Rambam Health Care Campus
Haifa, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2013
- Primary completion
- 30 Jan 2017
- Completion
- 30 Jan 2017
- Last update posted
- 31 Jul 2018
- Registered enrollment
- 511
- Registry id
- NCT01767155
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.